Fermented-milk bacteria: role in intestinal peristalsis regulation
Abstract
The aim of review. To demonstrate a role of fermented-milk bacteria, first of all Lactobacillus and Bifidumbacterium geni, and their metabolic products – short-chain fatty acids in regulation of peristalsis of the bowel.
Original positions. In clinical studies the effect of probiotic strains on severity of symptoms of functional bowel disorders is investigated. The greatest attention is given to the effects of Bifidobacterium animalis DN-173 010 strain (commercial name — ActiRegularis). It was found out, that probiotics containing various strains of Lacto- and Bifidobacteria, have mild purging action without the essential undesirable effects and reduce abdominal dyscomfort.
Conclusion. The product containing Bifidobacterium animalis DN-173 010 strain (commercial name — ActiRegularis) is effective for medical and preventive purposes for correction of frequency and improvement of stool consistence, decrease of abdominal distention both at functional bowel disorders, and at practically healthy people.
References
1. Agrawal A., Houghton L.A., Morris J. et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation // Aliment. Pharmacol. Ther. – 2008 Sep 17 [Epub. ahead of print].
2. Amenta M., Cascio M.T., Di Fiore P., Venturini I. Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight) // Acta Biomed. – 2006. – Vol. 77, N 3. – P. 157–162.
3. Bekkali N.L., Bongers M.E., van den Berg M.M. et al. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study // Nutr. J. – 2007. – Vol. 4, N 6. – P. 17.
4. Bixquert Jimйnez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? // Rev. Esp. Enferm. Dig. – 2009. – Vol. 101, N 8. – P. 553–564.
5. Cherbut C. Effects of short-chain fatty acids on gastrointestinal motility // Physiological and clinical aspects of short-chain fatty acids / Eds. J.H. Cummings, J.L. Rombeau, T. Sakata. – UK: Cambridge, Cambridge Univ. Press, 1995. – P. 191.
6. Chmielewska A., Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation // World J. Gastroenterol. 2010. – Vol. 16, N 1. – P. 69–75.
7. De Paula J.A., Carmuega E., Weill R. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation // Acta Gastroenterol. Latinoam. – 2008. – Vol. 38, N 1. – P. 16–25.
8. Drouault-Holowacz S., Bieuvelet S., Burckel A. et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome // Gastroenterol. Clin. Biol. – 2008. – Vol. 32, N 2. – P. 147–152.
9. Duez H., Pelletier C., Cools S. et al. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces // J. Appl. Microbiol. – 2000. – Vol. 88, N 6.
10. – P. 1019–1027.
11. Guyonnet D., Chassany O., Ducrotte P. et al. Effect of a fermented milk containing Bifidobacterium animalis
Review
For citations:
Shulpekova Yu.O. Fermented-milk bacteria: role in intestinal peristalsis regulation. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2010;20(3):68-73. (In Russ.)